| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-2 Weeks |
| Number of Subjects | 37 |
| Sex | Both Genders |
| Age Range | 30-44 |
| Body Types | Average |
Supplementation of a high dose of alanylglutamine (24g) daily for 10 days in subjects with HIV noted that supplementation, relative to glycine placebo, improved intestinal permeability as assessed by a lactulose:mannitol ratio but only in subjects reporting diarrhea in the last two weeks. No other biochemical effects of supplementation were observed.
